| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0095 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |